Home/ Stocks/ CCEL

Cryo-Cell International Inc.

CCEL XASE

$3.91 +0.03 (+0.77%) ▲ 15-min delayed

Open

$3.90

High

$3.93

Low

$3.90

Volume

4.0K

Market Cap

$31.28M

About Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Sector: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC Employees: 76 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$7.68M	$47.1K	$0.01
FY 2025	$31.57M	$-2,429,385	$-0.30
Q3 2025	$7.83M	$749.4K	$0.09
Q2 2025	$7.93M	$355.8K	$0.04

Related Market News

No specific coverage for CCEL yet. Check out our latest market news or earnings calendar.

Get CCEL Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Cryo-Cell International Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.